Masako Shimamura

Dr. Masako Shimamura


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
MMMaria Mojica
Maria Mojica
COChristopher P. Ouellette
Christopher P. Ouellette
ALAmy Leber
Amy Leber
MBM. Brian Becknell
M. Brian Becknell
MAMonica I. Ardura
Monica I. Ardura
SSSamuel A. Shelburne
Samuel A. Shelburne
Stenotrophomonas maltophilia is an emerging multidrug-resistant (MDR) opportunistic pathogen for which new antibiotic options are urgently needed. We report our clinical experience treating a 19-year-old renal transplant recipient who developed prolonged bacteremia due to metallo-β-lactamase-producing S. maltophilia refractory to conventional treatment. The infection recurred despite a prolonged course of colistimethate sodium (colistin) but resolved with the use of a novel drug combination with clinical efficacy against the patient's S. maltophilia isolate.

16 April 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MLMao Li
Mao Li
SBSrinivasa Rao Boddeda
Srinivasa Rao Boddeda
BCBo Chen
Bo Chen
QZQiang Zeng
Qiang Zeng
TSTrenton R. Schoeb
Trenton R. Schoeb
MSMasako Shimamura
Masako Shimamura
Human cytomegalovirus (HCMV) donor positive (D+) serostatus with acute rejection is associated with renal allograft loss, but the impact of recipient positive (R+) serostatus is unclear. In an allogeneic renal transplant model, antiviral natural killer (NK) and CD8+ T cell memory responses in murine CMV (MCMV) D+/R+ transplants were compared to D‐/R‐ and D+/R‐ transplants, with recipient infection varied by MCMV dose and strain. D+/R‐ transplants had high primary antiviral cytolytic (interferon‐γ+) and cytotoxic (granzyme B+) NK responses, whereas NK memory responses were lower in D+/R+ recipients receiving a high primary MCMV dose. Despite MCMV immunity, D+/R+ recipients receiving a low MCMV dose showed primary‐like high cytolytic and cytotoxic NK responses. D+/R+ transplants infected with different D/R strains had low cytolytic NK responses, but high cytotoxic NK responses. NK memory also induced a novel TNF‐α+ NK response among high‐ dose virus recipients. MCMV+ transplants had greater Th17 responses than MCMV uninfected transplants, and Th17 inhibition ameliorated graft injury. All MCMV+ recipients had similar CD8+ T cell responses. In sum, NK and Th17 responses, but not CD8+ T cells, varied according to conditions of primary recipient infection. This variability could contribute to variable graft outcomes in HCMV D+/R+ renal transplantation.

4 March 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
MSMasako Shimamura
Masako Shimamura
JKJuhyeong Kim
Juhyeong Kim
AMAlexandra K. Medoro
Alexandra K. Medoro
KFKaitlyn Flint
Kaitlyn Flint
IKIrina Kaptsan
Irina Kaptsan
PSPablo J. Sánchez
Pablo J. Sánchez
Congenital cytomegalovirus (cCMV) infection is diagnosed by positive urine or saliva testing within 21 days after birth. Beyond this age, newborn dried blood spot (DBS) PCR can retrospectively diagnose cCMV infection but has lower sensitivity than urine or saliva PCR testing. The DBS PCR may be negative due to the absence of blood DNAemia at birth or to the technical limit of detection for DBS PCR. The objective of this study was to distinguish these two possibilities by determining agreement between DBS and plasma CMV PCR tests among cCMV‐infected infants. This single center retrospective cohort study evaluated 70 cCMV‐infected infants diagnosed by a positive urine CMV PCR, who had a CMV DBS at birth and a plasma PCR test within 31 days after birth. Clinical characteristics and viral loads were compared between groups according to paired DBS and plasma PCR results. Test agreement was calculated using Cohen's kappa coefficient. The DBS PCR sensitivity was 71% compared to urine PCR. Of the 70 subjects, 49 (70%) subjects were DBS+ /plasma+ , 1 (1.4%) were DBS+ /plasma−, 14 (20%) were DBS−/plasma+ , and 6 (9%) were DBS−/plasma−. Agreement between the tests was fair (κ = 0.348, 95% CI 0.115‐0.581). Of the 20 subjects with DBS− tests, 6 (30%) had undetectable plasma DNAemia. Of the infants with DBS−/plasma+ PCR, plasma viral loads were significantly lower than infants with DBS+ /plasma+ PCR testing. Nearly a third of cCMV infected infants may be missed by DBS testing due to both biological and technical limitations of this method.

24 September 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
AMAlexandra K. Medoro
Alexandra K. Medoro
RDRavi Dhital
Ravi Dhital
PSPablo J. Sánchez
Pablo J. Sánchez
KFKaitlyn Flint
Kaitlyn Flint
BGBrianna Graber
Brianna Graber
MSMasako Shimamura
Masako Shimamura
BACKGROUND: Congenital cytomegalovirus (cCMV) infection can cause developmental impairment and sensorineural hearing loss (SNHL). To determine the relationship between immune responses to cCMV infection and neurologic sequelae, T cell responses were compared for their connection to clinical symptoms at birth and neurodevelopmental outcomes. METHODS: Thirty cCMV-infected and 15 uninfected infants were enrolled in a single-center prospective observational case-control study. T cell pp65-specific cytokine responses; CD57, CD28, and PD-1 expression; and memory subsets were compared. RESULTS: Infected neonates (73% symptomatic at birth) lacked pp65-specific cytokine-secreting T cells, with elevated frequencies of CD57 + , CD28 – , and PD-1 + CD8 + T cells and effector memory subsets. Though frequencies overlapped between cCMV symptom groups, asymptomatic infants had higher frequencies of CD57 + PD-1 + CD8 + T cells. Neonates with subsequent developmental delay lacked detectable CMV-specific T cell responses, with patterns resembling those of uninfected infants. Two children with progressive SNHL had high frequencies of PD-1 + CD8 + T cells over the first year compared with children without progressive SNHL. CONCLUSION: Similar to published reports, neonatal viral antigen–specific cytokine-secreting T cell responses were not detected, but overall patterns indicate that globally differentiated memory CD8 + T cell populations were induced by cCMV infection, with higher frequencies of terminally differentiated PD-1 + CD8 + T cells potentially associated with asymptomatic infection. In this cohort, a lack of in utero T cell differentiation was associated with developmental delay, and high frequencies of PD-1 + CD8 + T cells persisted only in children with progressive SNHL. Further work is needed to define the specificity of these T cells and their mechanistic connection to these outcomes. FUNDING: This study was funded through an intramural research award at Nationwide Children’s Hospital, the Pediatric Infectious Disease Society Fellowship Award funded by Stanley and Susan Plotkin and Sanofi Pasteur, the Abigail Wexner Research Institute at Nationwide Children’s Hospital, and the Pichichero Family Foundation Vaccines for Children Initiative Research Award from the Pediatric Infectious Diseases Society Foundation.

2 September 2025 in ASM Case Reports
Verified
Journal Article
Open access
MSMasako Shimamura
Masako Shimamura
BBBradford Becken
Bradford Becken
JTJessica Tansmore
Jessica Tansmore
MCMadison Cristinziano
Madison Cristinziano
LALawrence Abad
Lawrence Abad
KDKhalid M. Dousa
Khalid M. Dousa
Background: Mycobacterium abscessus ( M. abscessus ) infections are poorly responsive to antibiotics, with lower rates of clinical and microbiological clearance for macrolide-resistant isolates compared to macrolide-susceptible strains. Successful treatment of macrolide-resistant M. abscessus infection has not been reported for children. Case Summary: Here we report two children with macrolide-resistant M. abscessus infections who achieved clinical remission and microbiologic clearance using multi-drug treatment regimens including clofazimine, bedaquiline, linezolid or eravacycline, dual β-lactam therapy with meropenem and amoxicillin, and, in one case, phage therapy. Conclusion: Successful treatment of macrolide-resistant M. abscessus infections in children can be achieved using multi-drug regimens including novel dual β-lactam combinations and phage therapy. Dose adjustment with therapeutic drug monitoring can ameliorate some drug-induced toxicities in children.

20 July 2021 in Transplantation
Verified
Journal Article
Closed access
USUte Drn Saunders
Ute Drn Saunders
MLMao Li
Mao Li
SBSrinivasa R. Boddeda
Srinivasa R. Boddeda
SMSonya Ba Maher
Sonya Ba Maher
JGJessica Ba Ghere
Jessica Ba Ghere
MSMasako Shimamura
Masako Shimamura
Background.: Human cytomegalovirus (CMV) infection is associated with renal allograft dysfunction and loss, particularly in combination with acute rejection. Emerging literature suggests that non-HLA antibodies may contribute to antibody-mediated rejection, but pathogen-induced antibodies have not been investigated in this context. This study examines the presence of CMV-induced antibodies in murine CMV (MCMV)–infected renal allografts during acute rejection. Methods.: Intragraft immunoglobulin G (IgG) and complement C3 immunostaining were compared among allogeneic MCMV D−/R−, D+/R−, and D+/R+ renal transplants. Intragraft antibody deposition was examined in B cell–deficient recipients treated with MCMV immune sera. Antibody binding and complement-dependent cytotoxicity (CDC) of D−/R− and D+/R+ sera against infected renal tubular epithelial cells (TECs) were measured in vitro. IgG immunostaining was performed in D+/R+ allografts and native kidneys and in D+/R− allografts treated with ganciclovir to inhibit viral replication. Results.: D+/R− and D+/R+ transplants had more abundant IgG and C3 deposition compared with D−/R− recipients. Greater IgG deposition was associated with more severe allograft injury in B cell–deficient recipients treated with MCMV immune sera compared with nonimmune sera. D+/R+ sera induced greater CDC of infected TECs compared with D−/R− sera. Native kidneys had lower IgG deposition compared with allografts, despite similar organ viral loads. Ganciclovir-treated allografts had reduced IgG deposition compared with untreated allografts. Conclusions.: In this murine model, complement-fixing antibodies can deposit into MCMV-infected renal allografts, are associated with allograft damage, and can induce CDC of MCMV-infected renal TECs. The allogeneic response and viral replication may also contribute to intragraft antibody deposition.